| scholarly article | Q13442814 |
| P50 | author | Frank Bray | Q80648828 |
| P2093 | author name string | Elizabeth Ward | |
| Ahmedin Jemal | |||
| Jacques Ferlay | |||
| Melissa M Center | |||
| Otis Brawley | |||
| Joannie Lortet-Tieulent | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | prostate cancer | Q181257 |
| P304 | page(s) | 1079-1092 | |
| P577 | publication date | 2012-03-08 | |
| P1433 | published in | European Urology | Q15763991 |
| P1476 | title | International variation in prostate cancer incidence and mortality rates | |
| P478 | volume | 61 |
| Q38617142 | 10-Year Mortality in Men with Non-Metastatic Prostate Cancer in Norway |
| Q30936063 | 3D vs 2D laparoscopic radical prostatectomy in organ-confined prostate cancer: comparison of operative data and pentafecta rates: a single cohort study. |
| Q36531482 | 3p21.3 tumor suppressor gene RBM5 inhibits growth of human prostate cancer PC-3 cells through apoptosis |
| Q37140135 | A Clinicopathological Profile of Prostate Cancer in Trinidad and Tobago. |
| Q41661393 | A Molecular Modeling Study of the Hydroxyflutamide Resistance Mechanism Induced by Androgen Receptor Mutations |
| Q40226410 | A Pooled Analysis of 15 Prospective Cohort Studies on the Association between Fruit, Vegetable, and Mature Bean Consumption and Risk of Prostate Cancer |
| Q47098621 | A Single Nucleotide Polymorphism in HPGD Gene Is Associated with Prostate Cancer Risk |
| Q30626731 | A core outcome set for localised prostate cancer effectiveness trials: protocol for a systematic review of the literature and stakeholder involvement through interviews and a Delphi survey |
| Q37225298 | A genetic study and meta-analysis of the genetic predisposition of prostate cancer in a Chinese population |
| Q37705188 | A genome-wide association study of prostate cancer in West African men |
| Q45261777 | A longitudinal study on the impact of active surveillance for prostate cancer on anxiety and distress levels |
| Q92734070 | A molecule inducing androgen receptor degradation and selectively targeting prostate cancer cells |
| Q48196727 | A multicentre randomised controlled trial assessing whether MRI-targeted biopsy is non-inferior to standard transrectal ultrasound guided biopsy for the diagnosis of clinically significant prostate cancer in men without prior biopsy: a study protoco |
| Q35009235 | A phase 1 multiple-dose study of orteronel in Japanese patients with castration-resistant prostate cancer |
| Q35824866 | A pilot study to investigate if New Zealand men with prostate cancer benefit from a Mediterranean-style diet |
| Q55472658 | A population-based study of the influence of socioeconomic status on prostate cancer diagnosis in Taiwan. |
| Q36096487 | A retrospective analysis of Victorian and South Australian clinical registries for prostate cancer: trends in clinical presentation and management of the disease |
| Q30780322 | A review of continuous vs intermittent androgen deprivation therapy: redefining the gold standard in the treatment of advanced prostate cancer. Myths, facts and new data on a ″perpetual dispute″. |
| Q45276161 | A single centre experience of active surveillance as management strategy for low-risk prostate cancer in Ireland |
| Q58591800 | A single-nucleotide polymorphism (rs1805087) in the methionine synthase (METH) gene increases the risk of prostate cancer |
| Q36049662 | A systematic review and meta-analysis of tobacco use and prostate cancer mortality and incidence in prospective cohort studies |
| Q64981492 | A systematic review and meta-analysis on incidence of prostate cancer in Iran. |
| Q53176477 | Abiraterone acetate for metastatic castration-resistant prostate cancer after docetaxel failure: A randomized, double-blind, placebo-controlled phase 3 bridging study. |
| Q53103001 | Absorption, Distribution, and Excretion of the Investigational Agent Orteronel (TAK-700) in Healthy Male Subjects: A Phase 1, Open-Label, Single-Dose Study. |
| Q41048396 | Accuracy of Diffusion Weighted Images and MR Spectroscopy in Prostate Lesions - Our Experience with Endorectal Coil on 1.5 T MRI. |
| Q39882385 | Accurate prediction tools in prostate cancer require consistent assessment of included variables |
| Q37138594 | Active surveillance for prostate cancer |
| Q38712706 | Active surveillance for prostate cancer: a narrative review of clinical guidelines |
| Q35471903 | Active surveillance for prostate cancer: a systematic review of clinicopathologic variables and biomarkers for risk stratification. |
| Q38881773 | Adipocyte-derived monocyte chemotactic protein-1 (MCP-1) promotes prostate cancer progression through the induction of MMP-2 activity |
| Q39128628 | Adiponectin as a Potential Therapeutic Target for Prostate Cancer |
| Q92236440 | Adjuvant hormone therapy after radical prostatectomy in high-risk localized and locally advanced prostate cancer: First multicenter, observational study in China |
| Q47263668 | Adult body size, sexual history and adolescent sexual development, may predict risk of developing prostate cancer: Results from the New South Wales Lifestyle and Evaluation of Risk Study (CLEAR). |
| Q47096463 | Advances in Biomarkers for PCa Diagnostics and Prognostics-A Way towards Personalized Medicine. |
| Q35668631 | Age-Specific Cutoff Value for the Application of Percent Free Prostate-Specific Antigen (PSA) in Chinese Men with Serum PSA Levels of 4.0-10.0 ng/ml |
| Q36289592 | Alterations in androgen deprivation enhanced prostate-specific membrane antigen (PSMA) expression in prostate cancer cells as a target for diagnostics and therapy |
| Q26748679 | An Estimate of the Incidence of Prostate Cancer in Africa: A Systematic Review and Meta-Analysis |
| Q38829510 | An Sp1 Modulated Regulatory Region Unique to Higher Primates Regulates Human Androgen Receptor Promoter Activity in Prostate Cancer Cells |
| Q36638815 | An assessment of GLOBOCAN methods for deriving national estimates of cancer incidence |
| Q30994067 | An epidemiological analysis of potential associations between C-reactive protein, inflammation, and prostate cancer in the male US population using the 2009-2010 National Health and Nutrition Examination Survey (NHANES) data |
| Q41884768 | Androgen Metabolism Gene Polymorphisms, Associations with Prostate Cancer Risk and Pathological Characteristics: A Comparative Analysis between South African and Senegalese Men |
| Q38673660 | Androgen Receptor Deregulation Drives Bromodomain-Mediated Chromatin Alterations in Prostate Cancer |
| Q42315786 | Androgen receptor phosphorylation status at serine 578 predicts poor outcome in prostate cancer patients. |
| Q33621403 | Androgen synthesis inhibitors in the treatment of castration-resistant prostate cancer |
| Q83227835 | Androgen-regulated transcription of drives alternative splicing patterns in prostate cancer |
| Q35543453 | Androgen-regulation of the protein tyrosine phosphatase PTPRR activates ERK1/2 signalling in prostate cancer cells |
| Q38532432 | Anterior prostate biopsy at initial and repeat evaluation: is it useful to detect significant prostate cancer? |
| Q39245540 | Anti-proliferative effects of physiological concentrations of enterolactone in models of prostate tumourigenesis. |
| Q38600711 | Antiarrhythmic drug usage and prostate cancer: a population-based cohort study. |
| Q39326181 | Anticancer effect of deoxypodophyllotoxin induces apoptosis of human prostate cancer cells |
| Q92076804 | Appraising risk in active surveillance of localized prostate cancer |
| Q36405815 | Are strict vegetarians protected against prostate cancer? |
| Q38080685 | Artificial neural networks and prostate cancer--tools for diagnosis and management. |
| Q64078727 | Aspirin Exposure and Mortality Risk among Prostate Cancer Patients: A Systematic Review and Meta-Analysis |
| Q38420896 | Assessing the effectiveness of decision aids for decision making in prostate cancer testing: a systematic review. |
| Q42252484 | Assessment of association between common variants at 17q12 and prostate cancer risk-evidence from Serbian population and meta--analysis |
| Q35928166 | Association between MMP-2 expression and prostate cancer: A meta-analysis |
| Q28553140 | Association between Seminal Vesicle Invasion and Prostate Cancer Detection Location after Transrectal Systemic Biopsy among Men Who Underwent Radical Prostatectomy |
| Q64947212 | Association between dietary protein intake and prostate cancer risk: evidence from a meta-analysis. |
| Q43566439 | Association between metformin use and risk of prostate cancer and its grade |
| Q47618504 | Association between shift work and risk of prostate cancer: a systematic review and meta-analysis of observational studies |
| Q64074658 | Associations of CYP1 polymorphisms with risk of prostate cancer: an updated meta-analysis |
| Q92840799 | Associations of LIM kinase1 (LIMK1) gene single nucleotide polymorphisms with prostate cancer susceptibility in Chinese population |
| Q35256483 | Associations of plasma concentrations of dichlorodiphenyldichloroethylene and polychlorinated biphenyls with prostate cancer: a case-control study in Guadeloupe (French West Indies) |
| Q38701724 | Autophagy activated by the c-Jun N-terminal kinase-mediated pathway protects human prostate cancer PC3 cells from celecoxib-induced apoptosis |
| Q42371605 | BMI and serum lipid parameters predict increasing risk and aggressive prostate cancer in Chinese people |
| Q50074531 | Baculoviral IAP Repeat Containing 6 (BIRC6) Is a Predictor of Prognosis in Prostate Cancer. |
| Q33820579 | Baseline prostate-specific antigen measurements and subsequent prostate cancer risk in the Danish Diet, Cancer and Health cohort |
| Q33816831 | Benchmarking life expectancy and cancer mortality: global comparison with cardiovascular disease 1981-2010. |
| Q34375823 | Beyond abiraterone: new hormonal therapies for metastatic castration-resistant prostate cancer |
| Q39069174 | Beyond the limits of oxygen: effects of hypoxia in a hormone-independent prostate cancer cell line. |
| Q40934950 | Biomechanical modeling constrained surface-based image registration for prostate MR guided TRUS biopsy |
| Q40327142 | Biphasic ⁶⁸Ga-PSMA-HBED-CC-PET/CT in patients with recurrent and high-risk prostate carcinoma |
| Q52664872 | Body mass index and prostate cancer risk in the Carotene and Retinol Efficacy Trial. |
| Q40888600 | Body mass index in relation to serum prostate-specific antigen levels and prostate cancer risk |
| Q43119437 | C10orf116 Gene Copy Number Loss in Prostate Cancer: Clinicopathological Correlations and Prognostic Significance. |
| Q36148171 | CD147 and Prostate Cancer: A Systematic Review and Meta-Analysis. |
| Q92052777 | CE-MS-based urinary biomarkers to distinguish non-significant from significant prostate cancer |
| Q38409787 | CYP1A1 MspI polymorphism is associated with prostate cancer susceptibility: evidence from a meta-analysis |
| Q36967748 | Canadian Nurses' Perspectives on Prostate Cancer Support Groups: A Survey Study. |
| Q92306506 | Cancer Tsunami: Emerging Trends, Economic Burden, and Perioperative Implications |
| Q64085630 | Cancer burden in the Caribbean: an overview of the Martinique Cancer Registry profile |
| Q92506695 | Cancer control in the Caribbean island countries and territories: some progress but the journey continues |
| Q54974754 | Cancer detection rate of prebiopsy MRI with subsequent systematic and targeted biopsy are superior to non-targeting systematic biopsy without MRI in biopsy naïve patients: a retrospective cohort study. |
| Q38838215 | Cancer incidence profile in sub-Saharan African-born blacks in the United States: Similarities and differences with US-born non-Hispanic blacks. |
| Q39972544 | Cancer statistics for African Americans, 2016: Progress and opportunities in reducing racial disparities |
| Q38963293 | Cancer statistics for Hispanics/Latinos, 2015. |
| Q34479108 | Cancer survival in Cali, Colombia: A population-based study, 1995-2004. |
| Q47374969 | Capillarisin blocks prostate-specific antigen expression on activation of androgen receptor in prostate carcinoma cells |
| Q91807006 | Changing Incidence and Stage Distribution of Prostate Cancer in a Lithuanian Population-Evidence from National PSA-Based Screening Program |
| Q33779314 | Characteristics of prostate cancer detection rate (PCDR) in Chinese Han population under different prostate biopsy methods |
| Q38774654 | Chemotherapy for metastatic castrate-sensitive prostate cancer |
| Q39001029 | Cholesterol-induced activation of TRPM7 regulates cell proliferation, migration, and viability of human prostate cells. |
| Q47119316 | Clinical Significance of Measuring Global Hydroxymethylation of White Blood Cell DNA in Prostate Cancer: Comparison to PSA in a Pilot Exploratory Study |
| Q41595384 | Clinical and microbiological determinants of infection after transrectal prostate biopsy |
| Q40061414 | Clinical comparison of the efficacy of three different bowel preparation methods on the infectious complications following transrectal ultrasonography-guided prostate biopsy in nursing practice |
| Q64941197 | Clinical significance of bromodomain-containing protein 7 and its association with tumor progression in prostate cancer. |
| Q34506849 | Clinicopathologic differences between prostate cancers detected during initial and repeat transrectal ultrasound-guided biopsy in Korea |
| Q37368324 | Clinicopathological and Prognostic Factors in 106 Prostate Cancer Patients Aged ≤55 Years: A Single-Center Study in China. |
| Q35867402 | Cohort Profile Update: The National Prostate Cancer Register of Sweden and Prostate Cancer data Base--a refined prostate cancer trajectory |
| Q31051724 | Combination of prostate imaging reporting and data system (PI-RADS) score and prostate-specific antigen (PSA) density predicts biopsy outcome in prostate biopsy naïve patients |
| Q42376791 | Communicating risk in active surveillance of localised prostate cancer: a protocol for a qualitative study. |
| Q57799063 | Communication of prostate cancer cells with bone cells via extracellular vesicle RNA; a potential mechanism of metastasis |
| Q58101953 | Comparing diagnostic and prognostic performance of two-gene promoter methylation panels in tissue biopsies and urines of prostate cancer patients |
| Q64110402 | Comparison of Orthogonal NLP Methods for Clinical Phenotyping and Assessment of Bone Scan Utilization among Prostate Cancer Patients |
| Q58704818 | Comparison of Single and Prolonged Fluoroquinolone Prophylaxis and Risk Factors for Infectious Complications After Transrectal Prostate Biopsy |
| Q37600905 | Comparison of T2(*) mapping with diffusion-weighted imaging in the characterization of low-grade vs intermediate-grade and high-grade prostate cancer |
| Q57757464 | Comparison of [68Ga]Ga-PSMA-11 PET/CT with [18F]NaF PET/CT in the evaluation of bone metastases in metastatic prostate cancer patients prior to radionuclide therapy |
| Q51242769 | Comparison of free-hand transperineal mpMRI/TRUS fusion-guided biopsy with transperineal 12-core systematic biopsy for the diagnosis of prostate cancer: a single-center prospective study in China. |
| Q52989703 | Comparison of hybrid (68)Ga-PSMA PET/MRI and (68)Ga-PSMA PET/CT in the evaluation of lymph node and bone metastases of prostate cancer. |
| Q35089346 | Comparison of pathological and biochemical outcomes after radical prostatectomy in Korean patients with serum PSA ranges. |
| Q45905031 | Complications and quality of life after template-assisted transperineal prostate biopsy in patients eligible for focal therapy. |
| Q36111215 | Comprehensive comparison of molecular portraits between cell lines and tumors in breast cancer |
| Q34150179 | Copy number variation of GSTT1 and GSTM1 and the risk of prostate cancer in a Caribbean population of African descent |
| Q37665327 | Correlation between body mass index (BMI) and the Gleason score of prostate biopsies in Chinese population |
| Q35799949 | Cost of illness of the prostate cancer in Japan--a time-trend analysis and future projections |
| Q50856213 | Cost-effectiveness analysis of additional docetaxel for metastatic hormone-sensitive prostate cancer treated with androgen-deprivation therapy from a Chinese perspective. |
| Q47646760 | Cost-effectiveness analysis of multiparametric MRI with increased active surveillance for low-risk prostate cancer in Australia |
| Q57164767 | Current and Future Burden of Prostate Cancer in Songkhla, Thailand: Analysis of Incidence and Mortality Trends From 1990 to 2030 |
| Q47553703 | Current work environments: What problems are being faced by Japanese urologists? |
| Q38069776 | Custirsen (OGX-011): clusterin inhibitor in metastatic prostate cancer |
| Q39001013 | Cyclooxygenase 2 (rs2745557) Polymorphism and the Susceptibility to Benign Prostate Hyperplasia and Prostate Cancer in Egyptians |
| Q40359634 | Cytokines are early diagnostic biomarkers of graft-versus-host disease in liver recipients |
| Q49787455 | DAPK and CIP2A are involved in GAS6/AXL-mediated Schwann cell proliferation in a rat model of bilateral cavernous nerve injury. |
| Q41561252 | DNA vaccination for prostate cancer, from preclinical to clinical trials - where we stand? |
| Q60305412 | DT-13 Inhibits Proliferation and Metastasis of Human Prostate Cancer Cells Through Blocking PI3K/Akt Pathway |
| Q37302932 | Danish Prostate Cancer Registry - methodology and early results from a novel national database. |
| Q50922655 | Decreased expression of TCF12 contributes to progression and predicts biochemical recurrence in patients with prostate cancer. |
| Q26749077 | Demography and disease characteristics of prostate cancer in India |
| Q38067916 | Detectable prostate-specific antigen Nadir during androgen-deprivation therapy predicts adverse prostate cancer-specific outcomes: results from the SEARCH database |
| Q40417671 | Detection of High Grade Prostate Cancer among PLCO Participants Using a Prespecified 4-Kallikrein Marker Panel |
| Q47253086 | Detection of Local Recurrence with 3-Tesla MRI After Radical Prostatectomy: A Useful Method for Radiation Treatment Planning? |
| Q38603373 | Detection rate of prostate cancer following biopsy among the northern Han Chinese population: a single-center retrospective study of 1022 cases |
| Q42138605 | Determinants of Behavioral Intentions to Screen for Prostate Cancer in Omani Men. |
| Q33610844 | Determining the optimal number and location of cutoff points with application to data of cervical cancer |
| Q34957004 | Development and prospective multicenter evaluation of the long noncoding RNA MALAT-1 as a diagnostic urinary biomarker for prostate cancer |
| Q90825986 | Development and validation of a novel automated Gleason grade and molecular profile that define a highly predictive prostate cancer progression algorithm-based test |
| Q43582044 | Development and validation of nomograms to predict the recovery of urinary continence after radical prostatectomy: comparisons between immediate, early, and late continence |
| Q51803631 | Development of a Single Vial Kit Solution for Radiolabeling of 68Ga-DKFZ-PSMA-11 and Its Performance in Prostate Cancer Patients. |
| Q36121932 | Diagnostic and treatment factors associated with poor survival from prostate cancer are differentially distributed between regional and metropolitan Victoria, Australia |
| Q98386406 | Diagnostic performance of a nomogram incorporating cribriform morphology for the prediction of adverse pathology in prostate cancer at radical prostatectomy |
| Q35568239 | Diagnostic value of SFRP1 as a favorable predictive and prognostic biomarker in patients with prostate cancer |
| Q38215157 | Diagnostic value of urine prostate cancer antigen 3 test using a cutoff value of 35 μg/L in patients with prostate cancer |
| Q39100038 | Diet, Lifestyles, Family History, and Prostate Cancer Incidence in an East Algerian Patient Group. |
| Q95728490 | Dietary Nutrient Patterns and Prostate Cancer Risk: A Case-Control Study from Iran |
| Q35236576 | Dietary fat and reduced prostate cancer mortality: does the type of fat matter? |
| Q37037017 | Difference of opinion - Active surveillance in intermediate risk prostate cancer: is it safe? Opinion: Yes. |
| Q46687880 | Differences in prostate cancer grade, stage, and location in radical prostatectomy specimens from United States and Japan |
| Q40566791 | Differences in the aggressiveness of prostate cancer among Korean, Caucasian, and African American men: A retrospective cohort study of radical prostatectomy |
| Q58796641 | Differential expressions of integrin-linked kinase, β-parvin and cofilin 1 in high-fat diet induced prostate cancer progression in a transgenic mouse model |
| Q54269975 | Diffusion kurtosis imaging study of prostate cancer: preliminary findings. |
| Q90172181 | Discovery and Validation of Serum MicroRNAs as Early Diagnostic Biomarkers for Prostate Cancer in Chinese Population |
| Q35188264 | Disease-specific outcomes of radical prostatectomies in Northern Norway; a case for the impact of perineural infiltration and postoperative PSA-doubling time |
| Q38112122 | Dissecting Major Signaling Pathways throughout the Development of Prostate Cancer |
| Q38915711 | Dissecting major signaling pathways in prostate cancer development and progression: Mechanisms and novel therapeutic targets |
| Q93109945 | Distribution of Prostate Imaging Reporting and Data System score and diagnostic accuracy of magnetic resonance imaging-targeted biopsy: comparison of an Asian and European cohort |
| Q38923071 | Divergent effect of liver X receptor agonists on prostate-specific antigen expression is dependent on androgen receptor in prostate carcinoma cells |
| Q39633099 | Do skeletal-related events predict overall survival in men with metastatic castration-resistant prostate cancer? |
| Q41111232 | Does comorbidity interact with prostate cancer to increase mortality? A Danish cohort study of 45 326 prostate cancer patients diagnosed during 1995-2011. |
| Q88153962 | Does imprint cytology improve the accuracy of transrectal prostate needle biopsy? |
| Q38967167 | Down-modulation of Bcl-2 sensitizes PTEN-mutated prostate cancer cells to starvation and taxanes |
| Q54328984 | Down-regulation of Dicer and Ago2 is associated with cell proliferation and apoptosis in prostate cancer. |
| Q57492925 | Dynamic Contrast-Enhanced Imaging as a Prognostic Tool in Early Diagnosis of Prostate Cancer: Correlation with PSA and Clinical Stage |
| Q47152018 | Dynamical Binding Modes Determine Agonistic and Antagonistic Ligand Effects in the Prostate-Specific G-Protein Coupled Receptor (PSGR). |
| Q52647560 | Early abiraterone acetate treatment is beneficial in Japanese castration-resistant prostate cancer after failure of primary combined androgen blockade. |
| Q37671710 | Early dutasteride monotherapy in men with detectable serum prostate-specific antigen levels following radical prostatectomy: A prospective trial |
| Q34549831 | Early results of prostate cancer radiation therapy: an analysis with emphasis on research strategies to improve treatment delivery and outcomes |
| Q47127978 | Economic burden of the management of metastatic castrate-resistant prostate cancer in Italy: a cost of illness study |
| Q41020029 | Effect of Metformin, Rapamycin, and Their Combination on Growth and Progression of Prostate Tumors in HiMyc Mice |
| Q42023973 | Effect of gyromagnetic fields on human prostatic adenocarcinoma cells |
| Q39031198 | Effect of statins type on incident prostate cancer risk: a meta-analysis and systematic review. |
| Q90431464 | Effects of a six-month supervised physical exercise program on physical and cardio-metabolic profile and quality of life in patients with prostate cancer on androgen deprivation therapy: a pilot and feasibility study |
| Q58598348 | Effects of age and comorbidity on survival vary according to risk grouping among patients with prostate cancer treated using radical prostatectomy: A retrospective competing-risk analysis from the K-CaP registry |
| Q38754205 | Effects of cisplatin on the LSD1-mediated invasion and metastasis of prostate cancer cells |
| Q64256491 | Efficacy and safety of combined androgen blockade with antiandrogen for advanced prostate cancer |
| Q90298472 | Efficacy of Leuprorelide acetate (Eligard®) in daily practice in Brazil: a retrospective study with depot formulations in patients with prostate cancer |
| Q58733629 | Elevated expression of PTCD3 correlates with tumor progression and predicts poor prognosis in patients with prostate cancer |
| Q51238587 | Elevated levels of epithelial cell transforming sequence 2 predicts poor prognosis for prostate cancer. |
| Q33890197 | Endogenous and exogenous testosterone and prostate cancer: decreased-, increased- or null-risk? |
| Q87348740 | Endothelial nitric oxide synthase gene polymorphisms and prostate cancer risk in Serbian population |
| Q35753616 | Enhanced central memory cluster of differentiation 8(+) and tumor antigen-specific T cells in prostate cancer patients receiving repeated in situ adenovirus-mediated suicide gene therapy |
| Q46804879 | Enhanced expression of IMPDH2 promotes metastasis and advanced tumor progression in patients with prostate cancer |
| Q40311743 | Environmental factors and risk of aggressive prostate cancer among a population of New Zealand men - a genotypic approach |
| Q38152744 | Enzalutamide: a review of its use in metastatic, castration-resistant prostate cancer |
| Q38211257 | Enzalutamide: looking back at its preclinical discovery |
| Q92597173 | Epidemiology of Mortality Due to Prostate Cancer in Poland, 2000-2015 |
| Q93016574 | Epidemiology of Prostate Cancer in the Republic of Kazakhstan |
| Q27021674 | Epidemiology of prostate cancer in India |
| Q37270482 | Epidemiology of prostate cancer in the Asia-Pacific region |
| Q37647245 | Erectile dysfunction, masculinity, and psychosocial outcomes: a review of the experiences of men after prostate cancer treatment |
| Q90731611 | Establishment of reference intervals for serum [-2]proPSA (p2PSA), %p2PSA and prostate health index in healthy men |
| Q95261007 | Estimates of over-time trends in incidence and mortality of prostate cancer from 1990 to 2030 |
| Q46504038 | Ethnicity and ERG frequency in prostate cancer |
| Q36088325 | Evaluating Prostate Cancer Using Fractional Tissue Composition of Radical Prostatectomy Specimens and Pre-Operative Diffusional Kurtosis Magnetic Resonance Imaging |
| Q38154209 | Evaluation of the TMPRSS2:ERG fusion for the detection of prostate cancer: a systematic review and meta-analysis |
| Q42256590 | Evidence supporting the association of polyomavirus BK genome with prostate cancer |
| Q38135708 | Evolution of advanced technologies in prostate cancer radiotherapy |
| Q95261579 | Evolution of prostate cancer diagnosis: retrospective analysis of magnetic resonance imaging/ultrasound fusion guided biopsies protocol in routine practice and patients management |
| Q90343869 | Exosomes Derived from miR-143-Overexpressing MSCs Inhibit Cell Migration and Invasion in Human Prostate Cancer by Downregulating TFF3 |
| Q55229082 | Exploring the Interaction Mechanism Between Cyclopeptide DC3 and Androgen Receptor Using Molecular Dynamics Simulations and Free Energy Calculations. |
| Q53220940 | Expression of human kallikrein 1-related peptidase 4 (KLK4) and MET phosphorylation in prostate cancer tissue: immunohistochemical analysis. |
| Q42706628 | Expression of ribosomal proteins in normal and cancerous human prostate tissue. |
| Q31096808 | External Evaluation of a Novel Prostate Cancer Risk Calculator (ProstateCheck) Based on Data from the Swiss Arm of the ERSPC. |
| Q33725877 | Extranodal extension of lymph node metastasis influences recurrence in prostate cancer: a systematic review and meta-analysis |
| Q59789727 | FAM46B inhibits cell proliferation and cell cycle progression in prostate cancer through ubiquitination of β-catenin |
| Q38432866 | Febrile urinary tract infection after prostate biopsy and quinolone resistance |
| Q35771166 | Final Report of the Intergroup Randomized Study of Combined Androgen-Deprivation Therapy Plus Radiotherapy Versus Androgen-Deprivation Therapy Alone in Locally Advanced Prostate Cancer |
| Q41181147 | Fluoroquinolone-based antimicrobial prophylaxis in patients undergoing transrectal ultrasound-guided prostate biopsy. |
| Q45909143 | Focal cryoablation: a treatment option for unilateral low-risk prostate cancer. |
| Q35013272 | Forced LIGHT expression in prostate tumors overcomes Treg mediated immunosuppression and synergizes with a prostate tumor therapeutic vaccine by recruiting effector T lymphocytes |
| Q38323461 | Functional significance of aberrantly expressed microRNAs in prostate cancer |
| Q37022301 | G protein-coupled receptor GPR160 is associated with apoptosis and cell cycle arrest of prostate cancer cells |
| Q96225022 | GAS5 enhances natural killer cell-mediated killing by promoting ubiquitination of SESN2 in prostate cancer cells |
| Q58604507 | GSTM1 and GSTT1 Polymorphisms and Susceptibility to Prostate Cancer: A Case-Control Study of the Algerian Population |
| Q38518046 | Gene interference strategies as a new tool for the treatment of prostate cancer |
| Q40665254 | Genetic variants in the TEP1 gene are associated with prostate cancer risk and recurrence. |
| Q37700582 | Genetic variants within endothelial nitric oxide synthase gene and prostate cancer: a meta-analysis |
| Q34663656 | Genetic variation: effect on prostate cancer. |
| Q34536858 | Genetic variations of the ADIPOQgene and risk of prostate cancer in Chinese Han men. |
| Q91871630 | Genomic Alteration Burden in Advanced Prostate Cancer and Therapeutic Implications |
| Q52579829 | Geographic differences in baseline prostate inflammation and relationship with subsequent prostate cancer risk: results from the multinational REDUCE trial. |
| Q64066683 | Geographical Variations in Prostate Cancer Outcomes: A Systematic Review of International Evidence |
| Q57106013 | Global Trends and Prostate Cancer: A Review of Incidence, Detection, and Mortality as Influenced by Race, Ethnicity, and Geographic Location |
| Q91861232 | Global incidence comparisons and trends in ovarian germ cell tumors by geographic region in girls, adolescents and young women: 1988-2012 |
| Q51691612 | Glutathione Peroxidase 3 Inhibits Prostate Tumorigenesis in TRAMP Mice. |
| Q38379141 | Guidance on patient consultation. Current evidence for prostate-specific antigen screening in healthy men and treatment options for men with proven localised prostate cancer |
| Q37582166 | HER2 gene amplification in patients with prostate cancer: Evaluating a CISH-based method |
| Q39198017 | Hematologic changes during prostate cancer radiation therapy are dependent on the treatment volume |
| Q38954408 | High expression of ASPM correlates with tumor progression and predicts poor outcome in patients with prostate cancer |
| Q47097189 | High expression of PDLIM5 facilitates cell tumorigenesis and migration by maintaining AMPK activation in prostate cancer |
| Q58572138 | High levels of glioma tumor suppressor candidate region gene 1 predicts a poor prognosis for prostate cancer |
| Q49397682 | High-fat diet-induced adipokine and cytokine alterations promote the progression of prostate cancer in vivo and in vitro. |
| Q38119455 | High-resolution NMR spectroscopy of human body fluids and tissues in relation to prostate cancer. |
| Q58576173 | Higher baseline dietary fat and fatty acid intake is associated with increased risk of incident prostate cancer in the SABOR study |
| Q90665917 | Human methionine synthase A2756G polymorphism increases susceptibility to prostate cancer |
| Q41472454 | Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trial |
| Q47098821 | Identification of SPOP related metabolic pathways in prostate cancer |
| Q36979944 | Imaging and Markers as Novel Diagnostic Tools in Detecting Insignificant Prostate Cancer: A Critical Overview |
| Q34035683 | Imaging evaluation of prostate cancer with 18F-fluorodeoxyglucose PET/CT: utility and limitations |
| Q33618495 | Impact of DNA repair gene polymorphisms on the risk of biochemical recurrence after radiotherapy and overall survival in prostate cancer |
| Q39752786 | Impact of Genetic and Epigenetic Variations Within the FADS Cluster on the Composition and Metabolism of Polyunsaturated Fatty Acids in Prostate Cancer. |
| Q35771173 | Impact of Radiotherapy When Added to Androgen-Deprivation Therapy for Locally Advanced Prostate Cancer: Long-Term Quality-of-Life Outcomes From the NCIC CTG PR3/MRC PR07 Randomized Trial |
| Q33868433 | Impact of a protein-based assay that predicts prostate cancer aggressiveness on urologists' recommendations for active treatment or active surveillance: a randomized clinical utility trial |
| Q38449513 | Impact of international variation of prostate cancer on a predictive nomogram for biochemical recurrence in clinically localised prostate cancer |
| Q49185314 | Impact of metformin on serum prostate-specific antigen levels: Data from the national health and nutrition examination survey 2007 to 2008. |
| Q37688379 | Implication of NPM1 phosphorylation and preclinical evaluation of the nucleoprotein antagonist N6L in prostate cancer |
| Q41542390 | Implication of high risk human papillomavirus HR-HPV infection in prostate cancer in Indian population--a pioneering case-control analysis |
| Q57212953 | Importance of androgen-deprivation therapy during enzalutamide treatment in men with metastatic castration-resistant prostate cancer following chemotherapy: results from retrospective, multicenter data |
| Q36092572 | Improving Clinical Risk Stratification at Diagnosis in Primary Prostate Cancer: A Prognostic Modelling Study |
| Q30397277 | In Silico Analysis of the deleterious nsSNP's (missense) in the Homeobox domain of human HOXB13 gene responsible for hereditary prostate cancer |
| Q89540193 | In silico studies of piperazine derivatives as potent anti-proliferative agents against PC-3 prostate cancer cell lines |
| Q26748579 | In touch with your feminine side: how oestrogen metabolism impacts prostate cancer |
| Q37273869 | Incidence and mortality of prostate cancer and their relationship with the Human Development Index worldwide. |
| Q61805295 | Incidence of Prostate Cancer according to Metabolic Health Status: a Nationwide Cohort Study |
| Q39245025 | Incidence of intraductal carcinoma, multifocality and bilateral significant disease in radical prostatectomy specimens from Japan and United States |
| Q28082161 | Incidence of kidney, bladder, and prostate cancers in Korea: An update |
| Q53687040 | Incidence of metastasis and prostate-specific antigen levels at diagnosis in Gleason 3+4 versus 4+3 prostate cancer. |
| Q42118494 | Incidental detection of prostate-specific antigen-negative metastatic prostate cancer initially presented with solitary pulmonary nodule on fluorodeoxyglucose positron emission tomography/computed tomography |
| Q50672077 | Increased association of the ERG oncoprotein expression in advanced stages of prostate cancer in Filipinos. |
| Q47418114 | Index-Based Dietary Patterns and the Risk of Prostate Cancer. |
| Q38542639 | Inflammation and Cancer: What Can We Therapeutically Expect from Checkpoint Inhibitors? |
| Q89862172 | Influence of Diet and Nutrition on Prostate Cancer |
| Q39001625 | Influence of peripheral whole-blood microRNA-7 and microRNA-221 high expression levels on the acquisition of castration-resistant prostate cancer: evidences from in vitro and in vivo studies. |
| Q55455918 | Information and communication technology and climate change adaptation: Evidence from selected mining companies in South Africa. |
| Q42950544 | Integrated analysis of epigenomic and genomic changes by DNA methylation dependent mechanisms provides potential novel biomarkers for prostate cancer |
| Q42571904 | Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial |
| Q38856922 | International long-term trends and recent patterns in the incidence of leukemias and lymphomas among children and adolescents ages 0-19 years |
| Q54917990 | International survey of androgen deprivation therapy (ADT) for non-metastatic prostate cancer in 19 countries. |
| Q41842248 | Interracial differences in prostate cancer progression among patients from the United States, China and Japan |
| Q32179802 | Involvement of apoptotic pathways in docosahexaenoic acid-induced benefit in prostate cancer: Pathway-focused gene expression analysis using RT2 Profile PCR Array System |
| Q60936264 | Involvement of the glutamine RF‑amide peptide and its cognate receptor GPR103 in prostate cancer |
| Q35536948 | Is clinical stage T2c prostate cancer an intermediate- or high-risk disease? |
| Q53644144 | Is further screening of men with baseline PSA < 1 ng ml(-1) worthwhile? The discussion continues-Results of the Swiss ERSPC (Aarau). |
| Q45287773 | Is it appropriate to conduct conventional active surveillance for Asian men with low-risk prostate cancer? |
| Q35582296 | Is it necessary to perform week three dosimetric analysis in low-dose-rate brachytherapy for prostate cancer when day 0 dosimetry is done? A quality assurance assessment |
| Q57155050 | Is nonalcoholic fatty liver disease associated with the development of prostate cancer? A nationwide study with 10,516,985 Korean men |
| Q34798179 | Is prostate-specific antigen effective for population screening of prostate cancer? A systematic review |
| Q34325137 | Is there a role for body mass index in the assessment of prostate cancer risk on biopsy? |
| Q38024987 | Isolated, disseminated and circulating tumour cells in prostate cancer |
| Q99728124 | KLK3 and TMPRSS2 for molecular lymph-node staging in prostate cancer patients undergoing radical prostatectomy |
| Q38910483 | LKB1 suppresses proliferation and invasion of prostate cancer through hedgehog signaling pathway |
| Q41329517 | Latent prostate cancer in Japanese men who die unnatural deaths: A forensic autopsy study |
| Q40170080 | Left lobe of the prostate during clinical prostate cancer screening: the dark side of the gland for right-handed examiners. |
| Q51441414 | Lifestyle factors and prostate-specific antigen (PSA) testing in UK Biobank: Implications for epidemiological research. |
| Q49800256 | Limb-bud and Heart Overexpression Inhibits the Proliferation and Migration of PC3M Cells. |
| Q37612673 | Litchi seed extracts diminish prostate cancer progression via induction of apoptosis and attenuation of EMT through Akt/GSK-3β signaling |
| Q37553695 | LncRNAs and miRNAs: potential biomarkers and therapeutic targets for prostate cancer |
| Q58770077 | Long non-coding RNA NAP1L6 promotes tumor progression and predicts poor prognosis in prostate cancer by targeting Inhibin-β A |
| Q38941692 | Long-term cancer control outcomes of robot-assisted radical prostatectomy for prostate cancer treatment: a meta-analysis |
| Q43427594 | Long-term outcomes of combined androgen blockade therapy in stage IV prostate cancer |
| Q51549809 | Loss of PTEN expression in ERG-negative prostate cancer predicts secondary therapies and leads to shorter disease-specific survival time after radical prostatectomy. |
| Q89996544 | Low-Dose Abiraterone in Metastatic Prostate Cancer: Is It Practice Changing? Facts and Facets |
| Q38821290 | Lutetium-177-labelled anti-prostate-specific membrane antigen antibody and ligands for the treatment of metastatic castrate-resistant prostate cancer: a systematic review and meta-analysis. |
| Q46665942 | MANAGEMENT OF PROSTATE CANCER IN ACCRA, GHANA. |
| Q38918320 | MAPK and JAK/STAT pathways targeted by miR-23a and miR-23b in prostate cancer: computational and in vitro approaches. |
| Q38921911 | MLF1 interacting protein: a potential gene therapy target for human prostate cancer? |
| Q94335582 | MRI pathway and TRUS‐guided biopsy for detecting clinically significant prostate cancer |
| Q85523967 | MRI-guided core biopsy of the prostate in the supine position--introduction of a simplified technique using large-bore magnet systems |
| Q36080341 | Management of end-stage erectile dysfunction and stress urinary incontinence after radical prostatectomy by simultaneous dual implantation using a single trans-scrotal incision: surgical technique and outcomes. |
| Q38157338 | Management of prostate cancer in Asia: resource-stratified guidelines from the Asian Oncology Summit 2013. |
| Q37524412 | Manipulating the epigenome for the treatment of urological malignancies |
| Q42661858 | Matched comparison of robot-assisted, laparoscopic and open radical prostatectomy regarding pathologic and oncologic outcomes in obese patients |
| Q27022929 | Mechanisms linking excess adiposity and carcinogenesis promotion |
| Q37478700 | Medicinal properties of the Jamaican pepper plant Pimenta dioica and Allspice |
| Q44435099 | Medium-term oncological outcomes for extended vs saturation biopsy and transrectal vs transperineal biopsy in active surveillance for prostate cancer |
| Q99565353 | Melatonin and urological cancers: a new therapeutic approach |
| Q37696593 | Men's help-seeking in the first year after diagnosis of localised prostate cancer. |
| Q34514912 | Men's knowledge and attitudes towards dietary prevention of a prostate cancer diagnosis: a qualitative study |
| Q57283014 | Mendelian randomization does not support serum calcium in prostate cancer risk |
| Q36044730 | Metabolic syndrome-like components and prostate cancer risk: results from the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) study |
| Q33668168 | Metformin and prostate cancer: reduced development of castration-resistant disease and prostate cancer mortality |
| Q37315465 | Metformin does not affect risk of biochemical recurrence following radical prostatectomy: results from the SEARCH database. |
| Q36182935 | Metformin therapy and prostate cancer risk: a meta-analysis of observational studies |
| Q37357114 | MiRNA-296-3p-ICAM-1 axis promotes metastasis of prostate cancer by possible enhancing survival of natural killer cell-resistant circulating tumour cells |
| Q50558659 | Micronutrient intake and risk of prostate cancer in a cohort of middle-aged, Danish men. |
| Q46249376 | Migration from Mexico to the United States: A high-speed cancer transition |
| Q36619120 | Mitochondrial oncobioenergetic index: A potential biomarker to predict progression from indolent to aggressive prostate cancer |
| Q90705652 | Mitochondrial oncobioenergetics of prostate tumorigenesis |
| Q35141766 | Mobile application-based Seoul National University Prostate Cancer Risk Calculator: development, validation, and comparative analysis with two Western risk calculators in Korean men |
| Q36924745 | Model-based patterns in prostate cancer mortality worldwide |
| Q63966194 | Modernizing the diagnostic and decision-making pathway for prostate cancer |
| Q26752910 | Molecular aspects of prostate cancer with neuroendocrine differentiation |
| Q51325445 | Molecular mechanism of R-bicalutamide switching from androgen receptor antagonist to agonist induced by amino acid mutations using molecular dynamics simulations and free energy calculation. |
| Q26739708 | Molecular mechanisms underlying resistance to androgen deprivation therapy in prostate cancer |
| Q40114797 | Morbidity after transperineal prostate biopsy in 3000 patients undergoing 12 vs 18 vs more than 24 needle cores |
| Q49360753 | Mortality Rate and Years of Life Lost Due to Prostate Cancer in Yazd Province, Iran: A 10-year study. |
| Q38691219 | Multiparametric MRI/ultrasound fusion-guided biopsy decreases detection of indolent cancer in African-American men. |
| Q33668760 | Mutation of MED12 is not a frequent occurrence in prostate cancer of Korean patients |
| Q37538185 | Mutational load of the mitochondrial genome predicts pathological features and biochemical recurrence in prostate cancer |
| Q42878519 | Negative regulation of the androgen receptor gene through a primate-specific androgen response element present in the 5' UTR. |
| Q41708691 | Network meta-analysis of the efficacy and adverse effects of several treatments for advanced/metastatic prostate cancer |
| Q38650670 | New Genetic Markers for Prostate Cancer |
| Q39093621 | Next-generation sequencing of advanced prostate cancer treated with androgen-deprivation therapy |
| Q86128834 | Non-coding RNAs as biomarkers for metastatic prostate cancer |
| Q34176890 | Noncoding RNAs as novel biomarkers in prostate cancer |
| Q47110549 | Nuclear magnetic resonance spectroscopy as a new approach for improvement of early diagnosis and risk stratification of prostate cancer |
| Q28084566 | Nutrition, dietary interventions and prostate cancer: the latest evidence |
| Q36685022 | Obesity and prostate cancer: weighing the evidence |
| Q34641998 | Obesity increases the risk for high-grade prostate cancer: results from the REDUCE study |
| Q52673993 | Obesity was an independent risk factor for febrile infection after prostate biopsy: A 10-year single center study in South China. |
| Q45236978 | Occupational exposure to solar ultraviolet radiation and the risk of prostate cancer. |
| Q38404028 | Occupational risk factors for prostate cancer in an area of former coal, iron, and steel industries in Germany. Part 1: Results from a study performed in the 1980s |
| Q38302346 | On the relationship between tumor structure and complexity of the spatial distribution of cancer cell nuclei: a fractal geometrical model of prostate carcinoma |
| Q89993176 | Oncogenic Role of Secreted Engrailed Homeobox 2 (EN2) in Prostate Cancer |
| Q96645551 | Oncological outcomes for patients with locally advanced prostate cancer treated with neoadjuvant endocrine and external-beam radiation therapy followed by adjuvant continuous/intermittent endocrine therapy in an open-label, randomized, phase 3 trial |
| Q27004796 | Oncolytic adenovirus-mediated therapy for prostate cancer |
| Q47158515 | Open radical prostatectomy reproducing robot-assisted radical prostatectomy: Involving antegrade nerve sparing and continuous anastomosis |
| Q44991712 | Opinions from the experts: exploring what prostate cancer patients should know about post-operative radiotherapy |
| Q92534842 | Outpatient Robot-assisted Radical Prostatectomy: A Feasibility Study |
| Q92889931 | Overexpression levels of cripto-1 predict poor prognosis in patients with prostate cancer following radical prostatectomy |
| Q38800573 | Overexpression of long non-coding RNA LOC400891 promotes tumor progression and poor prognosis in prostate cancer |
| Q64064469 | Overexpression of malignant brain tumor domain containing protein 1 predicts a poor prognosis of prostate cancer |
| Q53262412 | Overexpression of signal transducer and activator of transcription (STAT-3 and STAT-5) transcription factors and alteration of suppressor of cytokine signaling (SOCS-1) protein in prostate cancer. |
| Q58207166 | PROCEE: a PROstate Cancer Evaluation and Education serious game for African Caribbean men |
| Q39357182 | PSMA, EpCAM, VEGF and GRPR as imaging targets in locally recurrent prostate cancer after radiotherapy |
| Q52593868 | Paraneoplastic sensorimotor polyneuropathy in prostatic adenocarcinoma: A case report. |
| Q59339937 | Pattern of care of prostate cancer patients across the Martinique: results of a population-based study in the Caribbean |
| Q55379815 | Percent free prostate-specific antigen for prostate cancer diagnosis in Chinese men with a PSA of 4.0-10.0 ng/mL: Results from the Chinese Prostate Cancer Consortium. |
| Q36748552 | Percent free prostate-specific antigen is effective to predict prostate biopsy outcome in Chinese men with prostate-specific antigen between 10.1 and 20.0 ng ml(-1). |
| Q61801043 | Persistent Homology for the Quantitative Evaluation of Architectural Features in Prostate Cancer Histology |
| Q38619233 | Pharmacokinetic and pharmacodynamic profile of degarelix for prostate cancer |
| Q49835554 | Phase I/II trial of dendritic cell-based active cellular immunotherapy with DCVAC/PCa in patients with rising PSA after primary prostatectomy or salvage radiotherapy for the treatment of prostate cancer. |
| Q34469245 | Phospho-Akt immunoreactivity in prostate cancer: relationship to disease severity and outcome, Ki67 and phosphorylated EGFR expression |
| Q52739150 | Phosphoglycerate mutase 1 knockdown inhibits prostate cancer cell growth, migration, and invasion. |
| Q33757541 | Physical activity and risk of prostate and bladder cancer in China: The South and East China case-control study on prostate and bladder cancer |
| Q40123622 | Physical after-effects in men undergoing prostate biopsy in routine clinical practice: Results from the PiCTure study |
| Q30244993 | Phytoestrogens and risk of prostate cancer: an updated meta-analysis of epidemiologic studies |
| Q38857178 | Plakophilin 1-deficient cells upregulate SPOCK1: implications for prostate cancer progression |
| Q37544161 | Planning for the future: cancer incidence projections in Switzerland up to 2019. |
| Q35988467 | Polymorphisms of Estrogen Metabolism-Related Genes and Prostate Cancer Risk in Two Populations of African Ancestry |
| Q30617117 | Pomegranate Extracts in the Management of Men's Urologic Health: Scientific Rationale and Preclinical and Clinical Data |
| Q42646205 | Postoperative statin use and risk of biochemical recurrence following radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database |
| Q90446299 | Potential application of lutetium-177-labeled prostate-specific membrane antigen-617 radioligand therapy for metastatic castration-resistant prostate cancer in a limited resource environment: Initial clinical experience after 2 years |
| Q28539777 | Pre- and post-operative nomograms to predict recurrence-free probability in korean men with clinically localized prostate cancer |
| Q38962397 | Preclinical activity of multiple-target gold(III)-dithiocarbamato peptidomimetics in prostate cancer cells and xenografts. |
| Q64255147 | Preclinical study using androgen receptor (AR) degradation enhancer to increase radiotherapy efficacy via targeting radiation-increased AR to better suppress prostate cancer progression |
| Q47805949 | Predicting the cancer burden in Catalonia between 2015 and 2025: the challenge of cancer management in the elderly |
| Q37496697 | Prediction of PSA Progression in Castration-Resistant Prostate Cancer Based on Treatment-Associated Change in Tumor Burden Quantified by 18F-Fluorocholine PET/CT |
| Q51021150 | Prediction of biochemical recurrence after robot-assisted radical prostatectomy: analysis of 784 Japanese patients. |
| Q42199068 | Prediction of mycoplasma hominis proteins targeting in mitochondria and cytoplasm of host cells and their implication in prostate cancer etiology |
| Q42736742 | Predictive factors of unfavorable prostate cancer in patients who underwent prostatectomy but eligible for active surveillance |
| Q59136276 | Predictive significance of - fusion in prostate cancer: a meta-analysis |
| Q36575795 | Preoperative erectile function and the pathologic features of prostate cancer |
| Q38609681 | Preprostate Biopsy Rectal Culture and Postbiopsy Sepsis |
| Q92833746 | Prevalence and clinical application of TMPRSS2-ERG fusion in Asian prostate cancer patients: a large-sample study in Chinese people and a systematic review |
| Q38950711 | Prevalence and management of prostate cancer among East Asian men: Current trends and future perspectives. |
| Q48021100 | Prevalence of prostate cancer on autopsy: cross-sectional study on unscreened Caucasian and Asian men. |
| Q34371057 | Prevention and early detection of prostate cancer |
| Q87917030 | Primary androgen deprivation therapy as monotherapy in unfavourable intermediate- and high-risk localised prostate cancer: a Singaporean single-centre perspective |
| Q57745959 | ProCare Trial: a phase II randomized controlled trial of shared care for follow-up of men with prostate cancer |
| Q39021762 | Probing the prostate tumour microenvironment I: impact of glucose deprivation on a cell model of prostate cancer progression. |
| Q43594513 | Probiotics: a proactive approach to health. A symposium report |
| Q58786195 | Profiling and bioinformatics analyses of differential circular RNA expression in prostate cancer cells |
| Q35244433 | Prognostic Utility of PET in Prostate Cancer. |
| Q38976733 | Prognostic role of genetic biomarkers in clinical progression of prostate cancer |
| Q47645575 | Prognostic value of 18F-choline PET/CT metabolic parameters in patients with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide. |
| Q38942896 | Pros-IT CNR: an Italian prostate cancer monitoring project |
| Q90583178 | Prospective study of cancer in Japanese patients with type 2 diabetes: the Fukuoka Diabetes Registry |
| Q39356200 | Prostate Biopsy in Active Surveillance Protocols: Immediate Re-biopsy and Timing of Subsequent Biopsies |
| Q40185753 | Prostate Cancer Prognostic Factors Among Asian Patients Born in the US Compared to Those Born Abroad |
| Q38854428 | Prostate Cancer and Aspirin Use: Synopsis of the Proposed Molecular Mechanisms |
| Q40402465 | Prostate Specific Antigen and Prostate Cancer in Chinese Men Undergoing Initial Prostate Biopsies Compared with Western Cohorts |
| Q38631091 | Prostate and breast cancer in four Nordic countries: A comparison of incidence and mortality trends across countries and age groups 1975-2013. |
| Q40116168 | Prostate biopsy: results and advantages of the transperineal approach--twenty-year experience of a single center |
| Q52803067 | Prostate cancer and the impact on couples: a qualitative metasynthesis. |
| Q37644685 | Prostate cancer antigen 3 moderately improves diagnostic accuracy in Chinese patients undergoing first prostate biopsy. |
| Q48333499 | Prostate cancer clinical presentation, incidence, mortality and survival in Guadeloupe over the period 2008-2013 from a population-based cancer registry |
| Q55216204 | Prostate cancer in Asia: A collaborative report. |
| Q38193300 | Prostate cancer in Asian men. |
| Q38431398 | Prostate cancer in Denmark 1978-2009--trends in incidence and mortality |
| Q30832800 | Prostate cancer in South Africa: pathology based national cancer registry data (1986-2006) and mortality rates (1997-2009) |
| Q90637783 | Prostate cancer incidence and mortality in the Baltic states, Belarus, the Russian Federation and Ukraine |
| Q30698121 | Prostate cancer incidence in 43 populations worldwide: An analysis of time trends overall and by age group. |
| Q47675170 | Prostate cancer incidence, mortality and survival trends in Estonia, 1995-2014. |
| Q41726337 | Prostate cancer mortality in Serbia, 1991-2010: a joinpoint regression analysis |
| Q28068688 | Prostate cancer screening in Brazil: should it be done or not? |
| Q51771288 | Prostate cancer screening in Europe and Asia. |
| Q88557081 | Prostate cancer screening: And the pendulum swings |
| Q39374516 | Prostate cancer trends in Asia |
| Q34465110 | Prostate cancer, prostate cancer death, and death from other causes, among men with metabolic aberrations |
| Q43985572 | Prostate cancer: Diabetes and prostate cancer--an open debate |
| Q26781093 | Prostate-Specific Antigen (PSA)-Based Population Screening for Prostate Cancer: An Evidence-Based Analysis |
| Q44658335 | Prostate-specific antigen doubling time as a progression criterion in an active surveillance programme for patients with localized prostate cancer |
| Q64945770 | Prostate-specific antigen-based screening in Afro-Caribbean men: a survey of members of the Caribbean Urological Association. |
| Q35211931 | Prostate-specific antigen-based screening: controversy and guidelines |
| Q43216762 | Prostatic adenocarcinoma with initial metastatic spread to the mandible |
| Q37628507 | Protocol for the ProCare Trial: a phase II randomised controlled trial of shared care for follow-up of men with prostate cancer |
| Q52593552 | Proton Beam Therapy Alone for Intermediate- or High-Risk Prostate Cancer: An Institutional Prospective Cohort Study. |
| Q30252103 | Psycho-oncology assessment in Chinese populations: a systematic review of quality of life and psychosocial measures. |
| Q38796656 | Quality of sleep in patients receiving androgen deprivation therapy for prostate cancer |
| Q90729984 | Quantifying the effect of biopsy lateral decubitus patient positioning compared to supine prostate MRI scanning on prostate translocation and distortion |
| Q41338779 | Quantitative urinary proteomics using stable isotope labelling by peptide dimethylation in patients with prostate cancer |
| Q38517738 | Radical Prostatectomy for Locally Advanced Prostate Cancer: Current Status |
| Q92509854 | Radical prostatectomy and simultaneous penile prosthesis implantation: a narrative review |
| Q38613772 | Recent progress in urinary proteome analysis for prostate cancer diagnosis and management |
| Q38543678 | Recepteur d'origine nantais (RON), more than a kinase: Role in castrate-resistant prostate cancer |
| Q34435885 | Recommendations on screening for prostate cancer with the prostate-specific antigen test |
| Q42720533 | Recurrent scrotal edema in a patient with radiation enteritis: A case report |
| Q90433178 | Recyclable SERS-Based Immunoassay Guided by Photocatalytic Performance of Fe3O4@TiO2@Au Nanocomposites |
| Q33762586 | Reduced expression of PinX1 correlates to progressive features in patients with prostate cancer |
| Q38765695 | Regret and fear in prostate cancer: The relationship between treatment appraisals and fear of recurrence in prostate cancer survivors. |
| Q35665891 | Repeat Targeted Prostate Biopsy under Guidance of Multiparametric MRI-Correlated Real-Time Contrast-Enhanced Ultrasound for Patients with Previous Negative Biopsy and Elevated Prostate-Specific Antigen: A Prospective Study. |
| Q35754518 | Residential Exposure to Road and Railway Noise and Risk of Prostate Cancer: A Prospective Cohort Study |
| Q38206962 | Restoring TGFβ1 pathway-related microRNAs: possible impact in metastatic prostate cancer development |
| Q57074362 | Risk factors for infectious complications following transrectal ultrasound-guided prostate biopsy |
| Q91834228 | Risk of cardiovascular events in men treated for prostate cancer compared with prostate cancer-free men |
| Q40216794 | Risk of malignant melanoma in men with prostate cancer: Nationwide, population-based cohort study |
| Q35028830 | Robot-assisted radical prostatectomy: a case series of the first 100 patients--constitutional introduction and implementation on the basis of comprehensive department of minimal invasive surgery center |
| Q35796878 | Role of Surgery in locally advanced prostate cancer |
| Q26998938 | Role of magnetic resonance imaging in defining a biopsy strategy for detection of prostate cancer |
| Q50122172 | Role of robot-assisted radical prostatectomy in locally advanced prostate cancer. |
| Q92863015 | Role of surgery in oligometastatic prostate cancer |
| Q28076110 | Role of systemic chemotherapy in metastatic hormone-sensitive prostate cancer |
| Q40594467 | Saturated fat intake and prostate cancer aggressiveness: results from the population-based North Carolina-Louisiana Prostate Cancer Project |
| Q41995379 | Secondary bladder cancer after anticancer therapy for prostate cancer: reduced comorbidity after androgen-deprivation therapy |
| Q92564290 | Secretome profiling of PC3/nKR cells, a novel highly migrating prostate cancer subline derived from PC3 cells |
| Q35658168 | Selenium and chronic diseases: a nutritional genomics perspective |
| Q41026893 | Serum 17β-estradiol fails as a marker in identification of aggressive tumour disease in patients with localized prostate cancer |
| Q36106260 | Serum adiponectin concentration in 2,939 Japanese men undergoing screening for prostate cancer |
| Q40099310 | Serum levels of 17-β-estradiol are not predictive of prostate cancer diagnosis and aggressiveness: results from an Italian biopsy cohort. |
| Q85445453 | Serum levels of chromogranin A are not predictive of high-grade, poorly differentiated prostate cancer: results from an Italian biopsy cohort |
| Q43463703 | Serum levels of sex hormone binding globulin (SHBG) are not predictive of prostate cancer diagnosis and aggressiveness: results from an Italian biopsy cohort |
| Q92626122 | Shared decision making for men facing prostate cancer treatment: a systematic review of randomized controlled trials |
| Q89861104 | Shift Work and Prostate Cancer: An Updated Systematic Review and Meta-Analysis |
| Q36303157 | Shorter GGN Repeats in Androgen Receptor Gene Would Not Increase the Risk of Prostate Cancer |
| Q24289204 | Should docetaxel be standard of care for patients with metastatic hormone-sensitive prostate cancer? Pro and contra |
| Q42180829 | Simultaneous treatment with statins and aspirin reduces the risk of prostate cancer detection and tumorigenic properties in prostate cancer cell lines |
| Q40644395 | Smoking effect on secondary bladder cancer after external beam radiotherapy for prostate cancer |
| Q88564843 | Spectrophotometric photodynamic diagnosis of prostate cancer cells excreted in voided urine using 5-aminolevulinic acid |
| Q65001193 | Spider peptide toxin lycosin-I induces apoptosis and inhibits migration of prostate cancer cells. |
| Q40288838 | Stability Assessment of Candidate Reference Genes in Urine Sediment of Prostate Cancer Patients for miRNA Applications. |
| Q47114787 | Stability analysis on the radioactive iodine-labelled prostate cancer-specific recombinant oncolytic adenovirus |
| Q92388229 | Stiffness of prostate gland measured by transrectal real-time shear wave elastography for detection of prostate cancer: a feasibility study |
| Q44847025 | Survival after radical prostatectomy for clinically localised prostate cancer: a population-based study. |
| Q48165118 | Survival by Hispanic ethnicity among patients with cancer participating in SWOG clinical trials |
| Q42643233 | Synergistic Effects of NDRG2 Overexpression and Radiotherapy on Cell Death of Human Prostate LNCaP Cells |
| Q55251510 | TGFβ-induced epithelial-to-mesenchymal transition in prostate cancer cells is mediated via TRPM7 expression. |
| Q37216993 | TRIIODOTHYRONINE ATTENUATES PROSTATE CANCER PROGRESSION MEDIATED BY β-ADRENERGIC STIMULATION |
| Q46831086 | TWIST overexpression predicts biochemical recurrence-free survival in prostate cancer patients treated with radical prostatectomy |
| Q55128284 | Targeting Splicing in Prostate Cancer. |
| Q36544125 | Targeting of cytosolic phospholipase A2α impedes cell cycle re-entry of quiescent prostate cancer cells |
| Q91050162 | Technologies for image-guided surgery for managing lymphatic metastases in prostate cancer |
| Q95260996 | Temporal trends of kidney cancer incidence and mortality from 1990 to 2016 and projections to 2030 |
| Q52571247 | Testosterone metabolites inhibit proliferation of castration- and therapy-resistant prostate cancer. |
| Q59808775 | The Emerging Role of Epitranscriptomics in Cancer: Focus on Urological Tumors |
| Q93100308 | The Impact of 68Ga-PSMA PET/CT and PET/MRI on the Management of Prostate Cancer |
| Q40393450 | The PI3K regulatory subunit gene PIK3R1 is under direct control of androgens and repressed in prostate cancer cells. |
| Q41912373 | The PSA tracker: a computerised health care system initiative in Northern Ireland |
| Q92480198 | The Proteogenomic Landscape of Curable Prostate Cancer |
| Q34577999 | The anti-proliferative effects of enterolactone in prostate cancer cells: evidence for the role of DNA licencing genes, mi-R106b cluster expression, and PTEN dosage. |
| Q55363445 | The burden of prostate cancer in Trinidad and Tobago: one of the highest mortality rates in the world. |
| Q37609167 | The burden of urinary incontinence and urinary bother among elderly prostate cancer survivors |
| Q38681961 | The cancer-associated cell migration protein TSPAN1 is under control of androgens and its upregulation increases prostate cancer cell migration |
| Q36364446 | The combination of prostate imaging reporting and data system version 2 (PI-RADS v2) and periprostatic fat thickness on multi-parametric MRI to predict the presence of prostate cancer |
| Q55334436 | The current state of prostate cancer treatment in Trinidad and Tobago. |
| Q36415375 | The dog prostate cancer (DPC-1) model: a reliable tool for molecular imaging of prostate tumors and metastases |
| Q57801339 | The effects of shared decision-making compared to usual care for prostate cancer screening decisions: a systematic review and meta-analysis |
| Q92245548 | The establishment of immune infiltration based novel recurrence predicting nomogram in prostate cancer |
| Q38096735 | The fat side of prostate cancer |
| Q34699785 | The host microenvironment influences prostate cancer invasion, systemic spread, bone colonization, and osteoblastic metastasis |
| Q50110237 | The impact of a family history of prostate cancer on the prognosis and features of the disease in Korea: results from a cross-sectional longitudinal pilot study. |
| Q52715355 | The impact of moderate wine consumption on the risk of developing prostate cancer. |
| Q33835864 | The molecular basis for ethnic variation and histological subtype differences in prostate cancer |
| Q40730608 | The nomogram conundrum: a demonstration of why a prostate cancer risk model in Turkish men underestimates prostate cancer risk in the USA. |
| Q45408608 | The oncological outcome and validation of Japan Cancer of the Prostate Risk Assessment score among men treated with primary androgen-deprivation therapy. |
| Q40267154 | The percentage of prostate-specific antigen (PSA) isoform [-2]proPSA and the Prostate Health Index improve the diagnostic accuracy for clinically relevant prostate cancer at initial and repeat biopsy compared with total PSA and percentage free PSA i |
| Q97570267 | The prognostic value and potential mechanism of Matrix Metalloproteinases among Prostate Cancer |
| Q84465604 | The prostate cancer conundrum revisited: further insights |
| Q37709933 | The provision of dietary and physical activity advice for men diagnosed with prostate cancer: a qualitative study of the experiences and views of health care professionals, patients and partners. |
| Q24604956 | The relationship between nutrition and prostate cancer: is more always better? |
| Q33882588 | The relevance of the procedures related to the physiotherapy in the interventions in patients with prostate cancer: short review with practice approach |
| Q41401823 | The roles of stress and social support in prostate cancer mortality |
| Q34807091 | The validity of the distress thermometer in prostate cancer populations |
| Q39342954 | Therapy assessment of bone metastatic disease in the era of 223radium. |
| Q48107095 | Third-line treatment and 177Lu-PSMA radioligand therapy of metastatic castration-resistant prostate cancer: a systematic review. |
| Q92549190 | Time Trends for Prostate Cancer Incidence from 2003 to 2013 in South Korea: An Age-Period-Cohort Analysis |
| Q43530076 | Time trends of cancer incidence and mortality in Catalonia during 1993-2007. |
| Q41636538 | Tn-MUC1 DC Vaccination of Rhesus Macaques and a Phase I/II Trial in Patients with Nonmetastatic Castrate-Resistant Prostate Cancer |
| Q92397856 | Transrectal Subharmonic Ultrasound Imaging for Prostate Cancer Detection |
| Q49441750 | Transrectal ultrasound-guided prostate rebiopsy: How many core sampling should be applied to which patient? |
| Q35921548 | Transrectal-ultrasound prostatic biopsy preparation: rectal enema vs. mechanical bowel preparation |
| Q92516554 | Treatment patterns of prostate cancer with bone metastasis in Beijing: A real-world study using data from an administrative claims database |
| Q64243690 | Trend and projection of mortality rate due to non-communicable diseases in Iran: A modeling study |
| Q35151890 | Trends and outcome from radical therapy for primary non-metastatic prostate cancer in a UK population |
| Q64230144 | Trends in Prostate Cancer Prevalence and Radical Prostatectomy Rate according to Age Structural Changes in South Korea between 2005 and 2015 |
| Q36901009 | Trends in prostate cancer incidence and mortality in Canada during the era of prostate-specific antigen screening |
| Q94657331 | Trends in the incidence rate of genitourinary system cancers in Turkey: 2004-2015 |
| Q40297420 | Trends of prostate cancer incidence and mortality in Shanghai, China from 1973 to 2009. |
| Q64265765 | Tumor-derived nanovesicles promote lung distribution of the therapeutic nanovector through repression of Kupffer cell-mediated phagocytosis |
| Q41193147 | Tumour heterogeneity poses a significant challenge to cancer biomarker research. |
| Q37037512 | Updated results from the European Randomized Study of Prostate-Specific Antigen (PSA) Screening for Prostate Cancer: are Asian countries encouraged to promote PSA screening? |
| Q90485716 | Upregulation of CXCR7 Is Associated with Poor Prognosis of Prostate Cancer |
| Q28079868 | Urologic cancer in Taiwan |
| Q26785709 | Urological malignancy in Hong Kong: the trend and the practice |
| Q61450673 | Usual adult occupation and risk of prostate cancer in West African men: the Ghana Prostate Study |
| Q92427051 | Validated Prospective Assessment of Quality of Life After Robot-Assisted Laparoscopic Prostatectomy: Beyond Continence and Erections |
| Q85319717 | Validation of TNM classification for metastatic prostatic cancer treated using primary androgen deprivation therapy |
| Q33898869 | Validation of a genomic classifier that predicts metastasis following radical prostatectomy in an at risk patient population. |
| Q27001399 | Validation of proposed prostate cancer biomarkers with gene expression data: a long road to travel |
| Q34971961 | WISP1/CCN4: a potential target for inhibiting prostate cancer growth and spread to bone |
| Q37551308 | What Are the Links of Prostate Cancer with Physical Activity and Nutrition? : A Systematic Review Article |
| Q36531954 | What Prevents Men Aged 40-64 Years from Prostate Cancer Screening in Namibia? |
| Q93272497 | Wide-field optical spectroscopy system integrating reflectance and spatial frequency domain imaging to measure attenuation-corrected intrinsic tissue fluorescence in radical prostatectomy specimens |
| Q50522084 | [Establishment of mouse model of bone metastasis of prostate cancer and breast cancer via femoral artery injection of tumor cells]. |
| Q52855360 | [Multimodal therapy of locally advanced prostate cancer]. |
| Q53760298 | [PSMA-targeted radioligand therapy in prostate cancer]. |
| Q58766572 | miR-17-3p Downregulates Mitochondrial Antioxidant Enzymes and Enhances the Radiosensitivity of Prostate Cancer Cells |
| Q49305492 | nNOS-positive minor-branches of the dorsal penile nerves is associated with erectile function in the bilateral cavernous injury model of rats. |
Search more.